Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT02743234 - Fecal Microbiota Transplantation (FMT) + Vancomycin vs Fidaxomicin vs. Vancomycin & Clostridioides difficile infection (CDI) (recurrent)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Fecal microbiota transplantation (FMT) is recommended for the treatment of recurrent Clostridioides difficile infection (CDI) (rCDI).
Hvas et al. 2019 Gastroenterology 156: 1324–32

The phase III trial involved consecutive adults with Clostridioides difficile infection (CDI) (recurrent) receiving Fecal Microbiota Transplantation (FMT) via colonoscopy or nasojejunal tube after 4–10 days of vancomycin (125 mg, 4 times daily) vs fidaxomicin (200 mg, twice daily) for 10 days vs [vancomycin](brain://OHfmccSf4k2KhiHI_97sTA/…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

NCT02743234 - Fecal Microbiota Transplantation (FMT) + Vancomycin vs Fidaxomicin vs. Vancomycin & Clostridioides difficile infection (CDI) (recurrent)

Welcome to meRfi Microbiome!

Navigation

Contents

AI Chat

Links